RBI posted Rs 3.38 lakh cr income on strong foreign asset returns, forex sales
MUMBAI:RBI's income rose 23% to Rs 3.38 lakh crore in FY25, driven by gains from foreign currency assets and dollar sales in the local market. This helped the central bank transfer a record Rs 2.7 lakh crore to the Govt, up from Rs 2.1 lakh crore in FY24.
RBI's balance sheet grew 8.2% to Rs 76 lakh crore in FY25 from Rs 70 lakh crore in FY24. One of the drivers of the rise in assets, was higher gold holdings, as global uncertainty boosted safe-haven demand. The rest came from a larger domestic investment portfolio, supported by OMO purchases for managing liquidity.
Overall interest income rose by 12% to Rs 2.11 lakh crore, while gains from foreign exchange transactions contributed to a 47% jump in other income, which stood at Rs 1.28 lakh crore.
The RBI's total income for the year increased by 23% to Rs 3.38 lakh crore, mainly driven by a 29% rise in interest earnings from overseas assets to Rs 1.33 lakh crore. However, part of the money was used by the RBI to strengthen its financial buffers.
The Contingency Fund rose by 27% to Rs 5.42 lakh crore, following a Rs 44,862 crore provision to align its Available Realised Equity (ARE) with the 7.5% target under the Economic Capital Framework.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
5 Books Warren Buffett Wants You to Read In 2025
Blinkist: Warren Buffett's Reading List
Undo
The ARE rose nearly 25% to Rs 5.72 lakh crore, while the Asset Development Fund remained unchanged at Rs 22,975 crore.
Domestic earnings, however, declined. Interest income from local investments dropped nearly 10% to Rs 77,327 crore, largely due to lower returns from rupee securities. Other income from domestic operations fell by 20% to Rs 2,143 crore. Total expenditure went up by 8% to Rs 69,714 crore, mainly due to higher costs for printing currency and employee benefits.
Stay informed with the latest
business
news, updates on
bank holidays
and
public holidays
.
AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
19 minutes ago
- News18
Niva Bupa Shares In Focus as Promoters Plan 7.2% Stake Sale Via Block Deals On Monday
Last Updated: June 02, 2025, 06:45 IST Niva Bupa Share Price: Shares of Niva Bupa Health Insurance Company Ltd. are in focus on Monday as Fettle Tone and Krishnan Ramchandra are expected to offload stakes via block deals on June 02. Niva Bupa shares in focus on Monday ahead of expected block deal. According to CNBC-TV18 report, Fettle Tone and Krishnan Ramchandra may sell 7.2% stake in the company through block deals at the offer price of Rs 82 per share, reflecting a discount of 11 per cent from the share's LTP. The total size of block deals may be as high as Rs 1,082 crore. Based on the March quarter shareholding pattern, promoters held a 55.98% stake in Niva Buba. Niva Bupa Q4 Results Niva Bupa Health Insurance Company reported a 31.2% year-on-year (YoY) jump in net profit at Rs 206 crore for the fourth quarter that ended March 31, 2025, compared to Rs 157 crore in Q4FY24. The insurer reported an 18.2% YoY rise in gross premiums written for the fourth quarter of FY25, reaching Rs 2,078.7 crore compared to Rs 1,759.4 crore in the same period last year. Net premium written increased by 21% YoY to Rs 1,672 crore from Rs 1,381.9 crore. However, underwriting profit declined 12.2% to Rs 57.6 crore from Rs 65.6 crore, while operating profit dropped sharply by 43.1% to Rs 94.9 crore from Rs 166.8 crore a year ago. The company's solvency ratio remained steady at 3.03% on a sequential basis. Earlier this year in February, Krishnan Ramachandran, MD and CEO of Niva Bupa Health Insurance Company, shared the company's target to grow 8-10% faster than the market over the next five years. He anticipates the sector will expand at a 15% compounded annual growth rate (CAGR). Ramachandran highlighted the extensive growth potential of the industry, emphasizing the need for continuous investment. 'This is a capital-intensive business. Therefore, it's about determining the sustained level of investments required to capitalize on this opportunity," he elaborated. View All Home Minister Amit Shah Assures Support to Northeastern States Amidst Devastating Floods | News18 Pakistan General's remarks on IWT; Spooked Pak Calls Abeyance Of IWT Act | India Pakistan News kashmir News | World Bicycle Day: Run For Unity Against Terrorism In Jammu Kashmir | News18 Covid-19 in India: Cases surge to 3,395; 4 deaths reported in 24 hours Terrorist Zakiur Rehman Lakhvi became father sitting in Paks jail, Owaisi shares shocking story View all Disclaimer: The views and investment tips by experts in this report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decisions.
Economic Times
21 minutes ago
- Economic Times
Stocks in news: Apollo Hospitals, IndiGo, Tata Motors, BPCL, Vodafone Idea
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Markets began the June expiry on a muted note and ended marginally lower, continuing the ongoing consolidation phase. In today's trade, shares of Apollo Hospitals Vodafone Idea among others will be in focus due to various news developments and fourth quarter CEO Pieter Elbers said that the three-month extension, granted till August 2025, for the 'damp-leased' aircraft from Turkish Airlines by DGCA will help the airline manage ongoing operations and customer Motors reported a decline in overall sales, with total sales down 8.6% year-on-year at 70,187 units in May 2025, compared to 76,766 units last year, while domestic sales dropped 10% to 67,429 sales rose 17% year-on-year to 4.31 lakh units in May, compared to 3.69 lakh units last year, with two-wheeler sales up 16% at 4.16 lakh units versus 3.59 lakh units in the same board has approved an investment in a joint venture with Tikitar and Shell India, aimed at manufacturing and marketing bitumen products. Alembic Pharmaceuticals has received a Form 483 from the US FDA with four observations for its API-I and API-II manufacturing units at India has filed the draft red herring prospectus (DRHP) for its subsidiary Bharat Coking Coal Ltd (BCCL) with Sebi. The proposed IPO will be an offer for sale (OFS) of up to 46.57 crore shares by Coal Reddy's said on Novo Nordisk's Semaglutide patents in India that the matter is currently Hospitals Enterprise reported fourth-quarter profit above market estimates on Friday, driven by higher demand for its healthcare products retailer Nykaa posted a fourth-quarter profit that nearly tripled year on year as premium brands continued to attract urban telco Vodafone Idea reported narrowing of losses for the March quarter to Rs 7,166 crore and its board greenlit fundraising of up to Rs 20,000 crore subject to shareholders' approval and statutory nods.
Economic Times
21 minutes ago
- Economic Times
What is LRS or RBI's Liberalised Remittance Scheme?
Funds can be remitted outside India for various purposes such as investments, travel, education and more The Reserve Bank of India provides the Liberalised Remittance Scheme. Indian residents can send money abroad. Individuals can remit up to $2,50,000 annually. This is without special permission from the RBI. The scheme is for education, travel, investments, and more. Tax is applicable depending on the purpose of remittance. Tired of too many ads? Remove Ads (Disclaimer: The opinions expressed in this column are that of the writer. The facts and opinions expressed here do not reflect the views of .) 1. LRS is a facility provided by the Reserve Bank of India (RBI) that allows resident individuals in India to send money abroad.2. Individuals can remit up to $2,50,000 per financial year (April– March) without special permission from the RBI3. Only resident individuals, including minors (through a guardian), are eligible. The scheme does not apply to companies, partnerships, or trusts.4. Funds can be remitted for various purposes, including education and medical expenses abroad, travel, gifting and donations, investments in foreign stocks, bonds, real estate, and deposits.5. Depending on the purpose, tax collected at source , or TCS, of up to 20% may be applicable on the remitted on this page is courtesy Centre for Investment Education and Learning (CIEL).Contributions by Girija Gadre, Arti Bhargava and Labdhi Mehta.
